Andra E Duncan1, Babak Kateby Kashy, Sheryar Sarwar, Akhil Singh, Olga Stenina-Adognravi, Steffen Christoffersen, Andrej Alfirevic, Shiva Sale, Dongsheng Yang, James D Thomas, Marc Gillinov, Daniel I Sessler. 1. From the Departments of Cardiothoracic Anesthesia (A.E.D., A.A., S. Sale), Outcomes Research (A.E.D., B.K.K., S. Sarwar, A.S., D.Y., D.I.S.), Molecular Cardiology (O.S.-A., S.C.), Quantitative Health Sciences (D.Y.), Cardiovascular Medicine (J.D.T.), and Cardiac Surgery (M.G.), Cleveland Clinic, Cleveland, Ohio. Current affiliations: Department of Anesthesiology, Northwestern University, Chicago, Illinois (B.K.K.); Department of Family Medicine, Case Medical Center, University Hospitals of Cleveland, Cleveland, Ohio (S.Sarwar); Hepatobiliary Anesthesia, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada (A.S.); Case Western Reserve University, Cleveland, Ohio (S.C.); and Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Chicago, Illinois (J.D.T.).
Abstract
BACKGROUND:Glucose-insulin-potassium (GIK) administration during cardiac surgery inconsistently improves myocardial function, perhaps because hyperglycemia negates the beneficial effects of GIK. The hyperinsulinemic normoglycemic clamp (HNC) technique may better enhance the myocardial benefits of GIK. The authors extended previous GIK investigations by (1) targeting normoglycemia while administering a GIK infusion (HNC); (2) using improved echocardiographic measures of myocardial deformation, specifically myocardial longitudinal strain and strain rate; and (3) assessing the activation of glucose metabolic pathways. METHODS: A total of 100 patients having aortic valve replacement for aortic stenosis were randomly assigned to HNC (high-dose insulin with concomitant glucose infusion titrated to normoglycemia) versus standard therapy (insulin treatment if glucose >150 mg/dl). The primary outcomes were left ventricular longitudinal strain and strain rate, assessed using speckle-tracking echocardiography. Right atrial tissue was analyzed for activation of glycolysis/pyruvate oxidation and alternative metabolic pathways. RESULTS:Time-weightedmean glucose concentrations were lower with HNC (127 ± 19 mg/dl) than standard care (177 ± 41 mg/dl; P < 0.001). Echocardiographic data were adequate in 72 patients for strain analysis and 67 patients for strain rate analysis. HNC did not improve myocardial strain, with an HNC minus standard therapy difference of -1.2% (97.5% CI, -2.9 to 0.5%; P = 0.11). Strain rate was significantly better, but by a clinically unimportant amount: -0.16 s (-0.30 to -0.03 s; P = 0.007). There was no evidence of increased glycolytic, pyruvate oxidation, or hexosamine biosynthetic pathway activation in right atrial samples (HNC, n = 20; standard therapy, 22). CONCLUSION: Administration of glucose and insulin while targeting normoglycemia during aortic valve replacement did not meaningfully improve myocardial function.
RCT Entities:
BACKGROUND:Glucose-insulin-potassium (GIK) administration during cardiac surgery inconsistently improves myocardial function, perhaps because hyperglycemia negates the beneficial effects of GIK. The hyperinsulinemic normoglycemic clamp (HNC) technique may better enhance the myocardial benefits of GIK. The authors extended previous GIK investigations by (1) targeting normoglycemia while administering a GIK infusion (HNC); (2) using improved echocardiographic measures of myocardial deformation, specifically myocardial longitudinal strain and strain rate; and (3) assessing the activation of glucose metabolic pathways. METHODS: A total of 100 patients having aortic valve replacement for aortic stenosis were randomly assigned to HNC (high-dose insulin with concomitant glucose infusion titrated to normoglycemia) versus standard therapy (insulin treatment if glucose >150 mg/dl). The primary outcomes were left ventricular longitudinal strain and strain rate, assessed using speckle-tracking echocardiography. Right atrial tissue was analyzed for activation of glycolysis/pyruvate oxidation and alternative metabolic pathways. RESULTS: Time-weighted mean glucose concentrations were lower with HNC (127 ± 19 mg/dl) than standard care (177 ± 41 mg/dl; P < 0.001). Echocardiographic data were adequate in 72 patients for strain analysis and 67 patients for strain rate analysis. HNC did not improve myocardial strain, with an HNC minus standard therapy difference of -1.2% (97.5% CI, -2.9 to 0.5%; P = 0.11). Strain rate was significantly better, but by a clinically unimportant amount: -0.16 s (-0.30 to -0.03 s; P = 0.007). There was no evidence of increased glycolytic, pyruvate oxidation, or hexosamine biosynthetic pathway activation in right atrial samples (HNC, n = 20; standard therapy, 22). CONCLUSION: Administration of glucose and insulin while targeting normoglycemia during aortic valve replacement did not meaningfully improve myocardial function.
Authors: Jean-Charles Preiser; Philippe Devos; Sergio Ruiz-Santana; Christian Mélot; Djillali Annane; Johan Groeneveld; Gaetano Iapichino; Xavier Leverve; Gérard Nitenberg; Pierre Singer; Jan Wernerman; Michael Joannidis; Adela Stecher; René Chioléro Journal: Intensive Care Med Date: 2009-07-28 Impact factor: 17.440
Authors: Victoria Delgado; Laurens F Tops; Rutger J van Bommel; Frank van der Kley; Nina Ajmone Marsan; Robert J Klautz; Michel I M Versteegh; Eduard R Holman; Martin J Schalij; Jeroen J Bax Journal: Eur Heart J Date: 2009-12 Impact factor: 29.983
Authors: Neil J Howell; Houman Ashrafian; Nigel E Drury; Aaron M Ranasinghe; Hussain Contractor; Henrik Isackson; Melanie Calvert; Lynne K Williams; Nick Freemantle; David W Quinn; David Green; Michael Frenneaux; Robert S Bonser; Jorge G Mascaro; Timothy R Graham; Stephen J Rooney; Ian C Wilson; Domenico Pagano Journal: Circulation Date: 2011-01-03 Impact factor: 29.690
Authors: Andra Ibrahim Duncan; Boris S Lowe; Mario J Garcia; Meng Xu; A Marc Gillinov; Tomislav Mihaljevic; Colleen G Koch Journal: Ann Thorac Surg Date: 2008-06 Impact factor: 4.330
Authors: Sjoerd A Mollema; Victoria Delgado; Matteo Bertini; M Louisa Antoni; Eric Boersma; Eduard R Holman; Marcel P M Stokkel; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax Journal: Circ Cardiovasc Imaging Date: 2009-10-09 Impact factor: 7.792
Authors: Abraham Sonny; Daniel I Sessler; Jing You; Babak Kateby Kashy; Sheryar Sarwar; Akhil K Singh; Shiva Sale; Andrej Alfirevic; Andra E Duncan Journal: J Anesth Date: 2017-07-13 Impact factor: 2.078
Authors: Abraham Sonny; Andrej Alfirevic; Shiva Sale; Nicole M Zimmerman; Jing You; A Marc Gillinov; Daniel I Sessler; Andra E Duncan Journal: Anesth Analg Date: 2018-05 Impact factor: 5.108
Authors: Kan Zhang; Richard Sheu; Nicole M Zimmerman; Andrej Alfirevic; Shiva Sale; A Marc Gillinov; Andra E Duncan Journal: J Cardiothorac Vasc Anesth Date: 2018-10-24 Impact factor: 2.628
Authors: Andra E Duncan; Daniel I Sessler; Hiroaki Sato; Tamaki Sato; Keisuke Nakazawa; George Carvalho; Roupen Hatzakorzian; Takumi Codere-Maruyama; Alaa Abd-Elsayed; Somnath Bose; Tamer Said; Maria Mendoza-Cuartas; Hyndhavi Chowdary; Edward J Mascha; Dongsheng Yang; A Marc Gillinov; Thomas Schricker Journal: Anesthesiology Date: 2018-06 Impact factor: 7.892
Authors: Andra E Duncan; Sheryar Sarwar; Babak Kateby Kashy; Abraham Sonny; Shiva Sale; Andrej Alfirevic; Dongsheng Yang; James D Thomas; Marc Gillinov; Daniel I Sessler Journal: Anesth Analg Date: 2017-02 Impact factor: 5.108
Authors: Chantal A Boly; Etto C Eringa; R Arthur Bouwman; Rob F P van den Akker; Frances S de Man; Ingrid Schalij; Stephan A Loer; Christa Boer; Charissa E van den Brom Journal: Cardiovasc Diabetol Date: 2016-09-20 Impact factor: 9.951